Compare PATK & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PATK | AMRX |
|---|---|---|
| Founded | 1959 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | 1994 | 2018 |
| Metric | PATK | AMRX |
|---|---|---|
| Price | $106.96 | $13.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $117.75 | $14.75 |
| AVG Volume (30 Days) | 411.4K | ★ 1.2M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 3.90 | 0.22 |
| Revenue | ★ $29,000,000.00 | N/A |
| Revenue This Year | $5.78 | $4.48 |
| Revenue Next Year | $6.51 | $7.13 |
| P/E Ratio | ★ $26.33 | $59.55 |
| Revenue Growth | ★ 262.50 | N/A |
| 52 Week Low | $75.27 | $7.02 |
| 52 Week High | $148.50 | $15.42 |
| Indicator | PATK | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 66.73 |
| Support Level | $106.34 | $12.50 |
| Resistance Level | $116.99 | $15.00 |
| Average True Range (ATR) | 5.75 | 0.36 |
| MACD | -0.44 | 0.19 |
| Stochastic Oscillator | 45.21 | 99.04 |
Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.